 | | | | | | | | | | | | | | | | | | | | | | | | |
| Subject: | | Southlander! |
| From: | |
Just Joan
|
posted
Wed, Jul 1 2009, 10:15pm
|
Found this and thought you might be very interested:
ScienceDaily: Your source for the latest research news and science breakthroughs -- updated daily
Science News
Share Blog Cite
Print Email Bookmark
Gene Therapy Demonstrates Benefit In Patients With Rheumatoid Arthritis
ScienceDaily (Jan. 27, 2009) — Researchers have reported the first clinical evidence that gene therapy reduces symptoms in patients with rheumatoid arthritis, an important milestone for this promising treatment which has endured a sometimes turbulent past.
See also:
Health & Medicine
* Arthritis
* Gene Therapy
* Joint Pain
* Personalized Medicine
* Diseases and Conditions
* Genes
Reference
* Arthritis
* Rheumatoid arthritis
* Osteoarthritis
* COX-2 inhibitor
Described in the February issue of the journal Human Gene Therapy the findings stem from a study of two patients with severe rheumatoid arthritis conducted in Germany and led by an investigator at Beth Israel Deaconess Medical Center (BIDMC).
Originally conceived as a means of treating genetic diseases, such as cystic fibrosis and hemophilia, gene therapy involves implanting a normal gene to compensate for a defective gene in the patient. The first clinical trial to test gene therapy was launched in 1990 for the treatment of a rare, genetic immunodeficiency disease.
"This study helps extend gene therapy research to nongenetic, nonlethal diseases," explains principal investigator Christopher Evans, PhD, Director of the Center for Advanced Orthopaedic Studies at BIDMC. "Rheumatoid arthritis [RA] is an extremely painful condition affecting multiple joints throughout the body. Arthritis is a good target for this treatment because the joint is a closed space into which we can inject genes," adds Evans, who is also the Maurice Muller Professor of Orthopaedic Surgery at Harvard Medical School.
A classic autoimmune disease, RA develops when, for unknown reasons, the body's immune system turns against itself, causing joints to become swollen and inflamed. If the disease is inadequately controlled, the tissues of the joint are eventually destroyed. Although anti-inflammatory agents and biologics can help to mitigate symptoms, there is no cure for the condition, estimated to affect more than 2 million individuals in the U.S. alone.
Evans has spent many years studying the molecules responsible for the breakdown of cartilage in patients with arthritis, identifying interleukin-1 as a good target. But, he adds, once he had this answer, another question was not far behind: How could he effectively reach the joints to block the actions of this protein?
Gene therapy provided the answer.
By implanting a gene in the affected joint, he was able to stimulate production of a human interleukin-1 receptor antagonist protein, which serves to block actions of the interleukin-1 protein.
"The idea is that by remaining in place, the new gene can continuously block the action of the interleukin-1 within the joints," says Evans. "In essence, the gene becomes its own little factory, continuously working to alleviate pain and swelling."
In 2005, in a study published in the Proceedings of the National Academy of Sciences (PNAS), Evans and colleagues demonstrated that the IL-1Ra gene could be safely transferred to human joints in patients with RA. In this new paper, the authors aimed to prove that the therapy was not only safe, but that it was of therapeutic benefit.
Two study subjects were recruited. (The number reduced from six study subjects following severe adverse events in an unrelated gene therapy trial taking place elsewhere, according to Evans.) Both subjects were postmenopausal females under the age of 75 with a diagnosis of advanced rheumatoid arthritis. After tissue was removed from the subjects' knuckle joints, a harmless retrovirus was inserted into the tissue cells, in order to serve as a "vector" to transport the gene into the patients' joints. After being placed in culture to grow and replicate, the cells were injected back into the afflicted joints.
After four weeks, patients reported reduced pain and swelling, according to Evans. "In one of the two subjects, these effects were dramatic, and the gene-treated joints remained pain-free even though other joints experience flares." Subsequent laboratory tests showed that tissues removed from the subject's joint tissue synthesized lower amounts of disease-related proteins, confirming that the reduction in pain and swelling resulted from the actions of the implanted gene.
"Existing treatments for rheumatoid arthritis are costly and need to be administered regularly," says Evans, adding that in addition to risk of side effects, not all patients respond well. "This paper provides us with the first real evidence that painful symptoms can indeed be lessened through gene therapy."
Ongoing work will focus on the use of gene therapy for the treatment of osteoarthritis, as well as rheumatoid arthritis.
This study was funded, in part, by grants from the National Institutes of Health and Orthogen, a German biotechnology company.
Study coauthors include Peter Wehling, Julio Reinecke, Axel Baltzer, Marcus Granrath, Klaus Schulitz, Carl Schultz, and Rudiger Krauspe of the University of Dusseldorf School of Medicine, Germany; Theresa Whiteside, Elaine Elder and Paul Robbins of the University of Pittsburgh School of Medicine; and Steven Ghivizzani of the University of Florida College of Medicine.
Adapted from materials provided by Beth Israel Deaconess Medical Center, via EurekAlert!, a service of AAAS.
Email or share this story:
| More
Need to cite this story in your essay, paper, or report? Use one of the following formats:
APA
MLA
Beth Israel Deaconess Medical Center (2009, January 27). Gene Therapy Demonstrates Benefit In Patients With Rheumatoid Arthritis. ScienceDaily. Retrieved July 2, 2009, from http://www.sciencedaily.com /releases/2009/01/090126153941.htm
Ads by Google
Advertise here
New Knee Pain Treatment
One Injection - 6 Months Relief. Get Your Free Knee Pain Relief Kit.
Get More Information Now
Rheumatoid Arthritis Info
Learn about a unique treatment for rheumatoid arthritis sufferers.
MoreRAinfo.com
Osteoarthritis
Learn about Osteoarthritis Chat with others. Find Doctors.
www.StopChronicDisease.com
Say Goodbye to Arthritis
Please read my story, this might be able to help your arthritis...
www.consumer-values.com/Arthritis
In six days, the pain
in my hips, knees and back were gone. Stop the pain now.
www.stimtein.com
Related Stories
A Possible New Phase For Rheumatoid Arthritis Treatment (Apr. 22, 2005) — New research published in Arthritis Research & Therapy found that very early rheumatoid arthritis is characterised by a distinct profile of T cell, macrophage and stromal cell related cytokines ... > read more
Antimalarial Drug Prevents Diabetes In Arthritis Patients, Study Suggests (Oct. 31, 2008) — New research sheds light on how an antimalarial drug may prevent the onset of diabetes in some high risk ... > read more
Women Who Breastfeed For More Than A Year Halve Their Risk Of Rheumatoid Arthritis (May 13, 2008) — Women who breast feed for longer have a smaller chance of getting rheumatoid arthritis, suggests a new study. The study also found that taking oral contraceptives, which are suspected to protect ... > read more
Top Anti-arthritis Drugs Cause Skin Disease (Apr. 19, 2005) — Members of the second most important family of drugs used to treat rheumatoid arthritis can cause serious dermatological conditions in a quarter of patients under treatment, reveals a study published ... > read more
High Exposure To Motor Oil Increases Chances Of Developing Arthritis (Oct. 3, 2005) — Occupational exposure to mineral oils, in particular hydraulic or motor oil, increases the risk of developing rheumatoid arthritis by 30%. These are the results of a study published today in ... > read more
Trial Shows Promise For Arthritis Drug (June 27, 2009) — A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well-tolerated and effective. Researchers have shown that treatment with masitinib ... > read more
One-fifth Of Rheumatoid Arthritis Patients In Drug-free Remission Following A Specific Treatment (June 20, 2007) — Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to new ... > read more
Anakinra For Rheumatoid Arthritis: A Modest Benefit With Some Risk, Study Suggests (Jan. 21, 2009) — New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic ... > read more
Search ScienceDaily
Joan |
|
|
|
|
| | | | | | | | | | | | | | | | | | | | |
|
